Sort   by:  
 Page size 
UnknownImproved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Not available
S-EPMC5053328 | biostudies-literature
UnknownTargeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Not available
S-EPMC10845766 | biostudies-literature
UnknownChanges in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).
Not available
S-EPMC9617815 | biostudies-literature
UnknownReal World Incidence and Etiology of Infectious Complications in Adults With Ph‐Negative Acute Lymphoblastic Leukemia Treated With the Pediatric‐Inspired GIMEMA LAL1913 Program. A Campus All Study
Not available
S-EPMC12337620 | biostudies-literature
UnknownLong-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.
Not available
S-EPMC11306272 | biostudies-literature
UnknownP1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL.
Not available
S-EPMC9430492 | biostudies-literature
UnknownManagement of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Not available
S-EPMC10538538 | biostudies-literature
UnknownTrabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.
Not available
S-EPMC6429746 | biostudies-literature
UnknownManagement of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
Not available
S-EPMC9185800 | biostudies-literature
UnknownClinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial.
Not available
S-EPMC12816975 | biostudies-literature
Sort   by:  
 Page size